Skip to main content

CAR T cells targeting Olfactory Receptor OR2H1 are an effective immunotherapeutic option in human epithelial tumors

Publication ,  Conference
BISWAS, S; Martin, A; Galindo, CMA; Mine, J; Payne, KK; Mandal, G; Chaurio, R; Powers, JJ; Sprenger, K; Rigolizzo, KE; Innamarato, P; Harro, C ...
Published in: The Journal of Immunology
May 1, 2022

Chimeric antigen receptor (CAR) T cells have been successful for hematological malignancies, but so far showed limited efficiency against solid tumors. Olfactory receptors are expressed in a variety of epithelial cancers, with a limited expression in healthy tissues. We quantified olfactory receptor OR2H1 expression in ovarian cancer, non-small cell lung cancer (NSCLC), breast cancer, and many normal tissues, and we found OR2H1 is expressed in multiple solid epithelial tumors but limited to testis among healthy human tissues. CAR T cells targeting OR2H1-extracellular domain were generated, and OR2H1-specific cytotoxic killing was confirmed, both in vitro and in vivo. Correspondingly, OR2H1-CAR T cells mediate significant therapeutic effects against OR2H1+ NSCLC and high-grade serous ovarian cancer. Interestingly, OR2H1 ablation significantly delays malignant progression of at least NSCLC, but OR2H1 expression is found to be essential for the cytotoxic effects of the OR2H1-CAR T cells. In summary, T cells directed against OR2H1-expressing tumor cells could be a potential therapeutic approach in future for treating OR2H1-expressing cancers.Supported by CA076292, R01CA157664, R01CA124515, R01CA178687, R01CA211913, U01CA232758 

Duke Scholars

Published In

The Journal of Immunology

DOI

EISSN

1550-6606

ISSN

0022-1767

Publication Date

May 1, 2022

Volume

208

Issue

1_Supplement

Start / End Page

117.16 / 117.16

Publisher

The American Association of Immunologists

Related Subject Headings

  • Immunology
  • 3204 Immunology
  • 3101 Biochemistry and cell biology
  • 1107 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
BISWAS, S., Martin, A., Galindo, C. M. A., Mine, J., Payne, K. K., Mandal, G., … Conejo-Garcia, J. R. (2022). CAR T cells targeting Olfactory Receptor OR2H1 are an effective immunotherapeutic option in human epithelial tumors. In The Journal of Immunology (Vol. 208, pp. 117.16-117.16). The American Association of Immunologists. https://doi.org/10.4049/jimmunol.208.supp.117.16
BISWAS, S. U. B. I. R., Alexandra Martin, Carmen Maria Anadon Galindo, Jessica Mine, Kyle K. Payne, Gunjan Mandal, Ricardo Chaurio, et al. “CAR T cells targeting Olfactory Receptor OR2H1 are an effective immunotherapeutic option in human epithelial tumors.” In The Journal of Immunology, 208:117.16-117.16. The American Association of Immunologists, 2022. https://doi.org/10.4049/jimmunol.208.supp.117.16.
BISWAS S, Martin A, Galindo CMA, Mine J, Payne KK, Mandal G, et al. CAR T cells targeting Olfactory Receptor OR2H1 are an effective immunotherapeutic option in human epithelial tumors. In: The Journal of Immunology. The American Association of Immunologists; 2022. p. 117.16-117.16.
BISWAS, S. U. B. I. R., et al. “CAR T cells targeting Olfactory Receptor OR2H1 are an effective immunotherapeutic option in human epithelial tumors.” The Journal of Immunology, vol. 208, no. 1_Supplement, The American Association of Immunologists, 2022, pp. 117.16-117.16. Crossref, doi:10.4049/jimmunol.208.supp.117.16.
BISWAS S, Martin A, Galindo CMA, Mine J, Payne KK, Mandal G, Chaurio R, Powers JJ, Sprenger K, Rigolizzo KE, Innamarato P, Harro C, Mehta S, Perez BA, Wenham RM, Conejo-Garcia JR. CAR T cells targeting Olfactory Receptor OR2H1 are an effective immunotherapeutic option in human epithelial tumors. The Journal of Immunology. The American Association of Immunologists; 2022. p. 117.16-117.16.

Published In

The Journal of Immunology

DOI

EISSN

1550-6606

ISSN

0022-1767

Publication Date

May 1, 2022

Volume

208

Issue

1_Supplement

Start / End Page

117.16 / 117.16

Publisher

The American Association of Immunologists

Related Subject Headings

  • Immunology
  • 3204 Immunology
  • 3101 Biochemistry and cell biology
  • 1107 Immunology